SCHEMBL5207905

SCHEMBL5207905

Cc1csc(NC(=O)c2nc(O)cc(S(C)(=O)=O)c2NC(=O)OC(C)(C)C)n1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.47
RAB9A P51151 6/20 0.47
ALDH1A1 P00352 2/20 0.47
GAA P10253 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
GCK P35557 11/20 0.46
MAPT P10636 1/20 0.43
HPGD P15428 2/20 0.42
RECQL P46063 1/20 0.42
GRM5 P41594 2/20 0.41
KDM4E B2RXH2 2/20 0.41
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TP53 P04637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
RCE1 Q9Y256 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1691027 0.77 MAPT (0.55) NPC1RAB9AALDH1A1GAAMAPT
SCHEMBL5207892 0.71 METAP1 (0.44) NPC1RAB9AALDH1A1GAAMEN1
SCHEMBL4911124 0.70 METAP1 (0.47) NPC1RAB9AALDH1A1GAAMEN1
SCHEMBL27333980 0.67 GLS (0.52) NPC1RAB9AALDH1A1GAAKMT2A
SCHEMBL27323009 0.67 MAPK1 (0.62) NPC1RAB9AALDH1A1MAPTKDM4E
SCHEMBL27320005 0.66 HTT (0.60) NPC1RAB9AGAAKMT2AMAPT
SCHEMBL8918968 0.65 HTT (0.50) NPC1RAB9AGAAKMT2AMAPT
SCHEMBL27321055 0.65 GAA (0.49) NPC1RAB9AALDH1A1GAAMAPT
SCHEMBL27318211 0.65 HTT (0.50) NPC1RAB9AGAAKMT2AMAPT
SCHEMBL17658949 0.64 CA1 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1858854-A1 PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2007-11-28 EP disclosed
WO-2006094639-A1 PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2006-09-14 WO disclosed